AdaptHealth (AHCO) Stock Price, Quote, News & History | Benzinga

SPY777.54−0.07%QQQ742.87−0.42%BTC/USD83,122.01+0.02%DIA515.75−0.42%GLD380.96−0.31%TLT78.41+0.46%

AdaptHealth Corp (AHCO) Stock Price, Quote, News & History

AHCONASDAQ

Trade with Public

Trade with Public

$6.33

0.193.09%

Last update: Oct 13, 4:00 PM

$6.22

0.081.3%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$6.20

Close

$6.33

Volume / Avg.

2.13M / 2.87M

Day Range

$6.33 - $6.35

52 Wk Range

5.21 - 13.43

Market Cap

$819.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

9.57%

Days to Cover

3.93

Recent AdaptHealth Corp. News

Crude Oil Down Over 5%; McDonald's Earnings Top Views

U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.

Avi Kapoor

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.

Avi Kapoor

AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems

AdaptHealth disclosed a material cyberattack involving patient data and insurance billing passwords while saying operations remain unaffected.

Vandana Singh

IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating changes, see analyst ratings page.

Avi Kapoor

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

583.27M

Investing Cash Flow (TTM)

-624.38M

Financing Cash Flow (TTM)

15.76M

Free Cash Flow (TTM)

97.68M

Capital Expenditure (TTM)

-485.59M

Net Change in Cash (TTM)

-25.34M

Analyst Trends and Forecast

3

May

2

Jul

3

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.83B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.25

PB Ratio (TTM)

0.60

Earnings Yield % (TTM)

-27.78%

Earnings Yield % (FWD)

-3.57%

EV / EBITDA (TTM)

9.84

Price / EBITDA (TTM)

2.89

Price / Free Cash Flow (TTM)

8.55

Book Value / Share

$10.33

Company Debt

Total Debt

$1.89B

LT Debt

$1.88B

LT Debt Issuance (TTM)

$575.00M

LT Debt Repayment (TTM)

-$518.25M

Total Cash

$43.29M

Debt to Equity

1.50

Issuance of Debt (TTM)

$56.75M

Repayment of Debt (TTM)

-$518.25M